{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:46:22Z","timestamp":1784634382655,"version":"3.55.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["GZR-2012\u2013009"],"award-info":[{"award-number":["GZR-2012\u2013009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Traditional Chinese Medicine Technology Development Fund Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41433-025-03665-w","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T23:38:25Z","timestamp":1740094705000},"page":"1254-1263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-human primates as preclinical models for optic nerve research: advancing insights into their application and potential"],"prefix":"10.1038","volume":"39","author":[{"given":"Lijie","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8933-4482","authenticated-orcid":false,"given":"Ningli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3199-0492","authenticated-orcid":false,"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"3665_CR1","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","volume":"9","author":"MJ Burton","year":"2021","unstructured":"Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, et al. The Lancet Global Health Commission on Global Eye Health: Vision Beyond 2020. Lancet Glob Health. 2021;9:e489\u2013e551.","journal-title":"Lancet Glob Health"},{"key":"3665_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/09286586.2021.1918177","volume":"29","author":"EA Lundeen","year":"2022","unstructured":"Lundeen EA, Saydah S, Ehrlich JR, Saaddine J. Self-reported vision impairment and psychological distress in US adults. Ophthalmic Epidemiol. 2022;29:171\u201381.","journal-title":"Ophthalmic Epidemiol"},{"key":"3665_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2021.09.010","volume":"129","author":"DB Rein","year":"2022","unstructured":"Rein DB, Wittenborn JS, Zhang P, Sublett F, Lamuda PA, Lundeen EA, et al. The economic burden of vision loss and blindness in the United States. Ophthalmology. 2022;129:369\u201378.","journal-title":"Ophthalmology"},{"key":"3665_CR4","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/s41433-024-03152-8","volume":"38","author":"S Ambika","year":"2024","unstructured":"Ambika S, Lakshmi P. Infectious optic neuropathy (ION), how to recognise it and manage it. Eye. 2024;38:2302\u201311.","journal-title":"Eye"},{"key":"3665_CR5","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/s41433-024-03129-7","volume":"38","author":"RJ Blanch","year":"2024","unstructured":"Blanch RJ, Joseph IJ, Cockerham K. Traumatic optic neuropathy management: a systematic review. Eye. 2024;38:2312\u20138.","journal-title":"Eye"},{"key":"3665_CR6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/s41433-024-03187-x","volume":"38","author":"MTM Wang","year":"2024","unstructured":"Wang MTM, Meyer JA, Danesh-Meyer HV. Neuro-ophthalmic evaluation and management of pituitary disease. Eye. 2024;38:2279\u201388.","journal-title":"Eye"},{"key":"3665_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.661938","volume":"12","author":"US Kim","year":"2021","unstructured":"Kim US, Mahroo OA, Mollon JD, Yu-Wai-Man P. Retinal ganglion cells-diversity of cell types and clinical relevance. Front Neurol. 2021;12:661938.","journal-title":"Front Neurol"},{"key":"3665_CR8","first-page":"2002","volume":"37","author":"I Selles-Navarro","year":"1996","unstructured":"Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, Ruiz-Gomez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Investig Ophthalmol Vis Sci. 1996;37:2002\u201314.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100799","volume":"75","author":"IH Pang","year":"2020","unstructured":"Pang IH, Clark AF. Inducible rodent models of glaucoma. Prog Retin Eye Res. 2020;75:100799.","journal-title":"Prog Retin Eye Res"},{"key":"3665_CR10","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1167\/iovs.03-0137","volume":"44","author":"M Aihara","year":"2003","unstructured":"Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Investig Ophthalmol Vis Sci. 2003;44:4314\u201320.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0014-4835(95)80056-5","volume":"61","author":"E Garcia-Valenzuela","year":"1995","unstructured":"Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61:33\u201344.","journal-title":"Exp Eye Res"},{"key":"3665_CR12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1167\/iovs.09-3921","volume":"52","author":"PA Samsel","year":"2011","unstructured":"Samsel PA, Kisiswa L, Erichsen JT, Cross SD, Morgan JE. A novel method for the induction of experimental glaucoma using magnetic microspheres. Investig Ophthalmol Vis Sci. 2011;52:1671\u20135.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.exer.2006.01.025","volume":"83","author":"JH Urcola","year":"2006","unstructured":"Urcola JH, Hernandez M, Vecino E. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp Eye Res. 2006;83:429\u201337.","journal-title":"Exp Eye Res"},{"key":"3665_CR14","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1167\/iovs.02-0646","volume":"44","author":"H Levkovitch-Verbin","year":"2003","unstructured":"Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Investig Ophthalmol Vis Sci. 2003;44:3388\u201393.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1076\/ceyr.24.6.458.8596","volume":"24","author":"B Li","year":"2002","unstructured":"Li B, Pang IH, Barnes G, McLaughlin M, Holt W. A new method and device to induce transient retinal ischemia in the rat. Curr Eye Res. 2002;24:458\u201364.","journal-title":"Curr Eye Res"},{"key":"3665_CR16","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1167\/iovs.05-0299","volume":"47","author":"Y Kitaoka","year":"2006","unstructured":"Kitaoka Y, Kitaoka Y, Kwong JM, Ross-Cisneros FN, Wang J, Tsai RK, et al. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Investig Ophthalmol Vis Sci. 2006;47:1448\u201357.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/archopht.1957.00940010205006","volume":"58","author":"DR Lucas","year":"1957","unstructured":"Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol. 1957;58:193\u2013201.","journal-title":"AMA Arch Ophthalmol"},{"key":"3665_CR18","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s10571-022-01280-x","volume":"43","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Wu S, Yan X, Liu Q, Lin D, Zhang J, et al. Human Pro370Leu mutant myocilin induces the phenotype of open-angle glaucoma in transgenic mice. Cell Mol Neurobiol. 2023;43:2021\u201333.","journal-title":"Cell Mol Neurobiol"},{"key":"3665_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.900777","volume":"10","author":"X Yan","year":"2022","unstructured":"Yan X, Wu S, Liu Q, Cheng Y, Zhang J, Wang N. Myocilin gene mutation induced autophagy activation causes dysfunction of trabecular meshwork cells. Front Cell Dev Biol. 2022;10:900777.","journal-title":"Front Cell Dev Biol"},{"key":"3665_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41420-021-00432-0","volume":"7","author":"S Zhang","year":"2021","unstructured":"Zhang S, Shao Z, Liu X, Hou M, Cheng F, Lei D, et al. The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro. Cell Death Discov. 2021;7:49.","journal-title":"Cell Death Discov"},{"key":"3665_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1084\/jem.20021603","volume":"197","author":"E Bettelli","year":"2003","unstructured":"Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med. 2003;197:1073\u201381.","journal-title":"J Exp Med"},{"key":"3665_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02623-7","volume":"19","author":"Y Morita","year":"2022","unstructured":"Morita Y, Itokazu T, Nakanishi T, Hiraga SI, Yamashita T. A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations. J Neuroinflam. 2022;19:263.","journal-title":"J Neuroinflam"},{"key":"3665_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","volume":"87","author":"P McGonigle","year":"2014","unstructured":"McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling translation. Biochem Pharm. 2014;87:162\u201371.","journal-title":"Biochem Pharm"},{"key":"3665_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-02796-6","volume":"23","author":"J Wu","year":"2023","unstructured":"Wu J, Liu W, Zhu S, Liu H, Chen K, Zhu Y, et al. Design, methodology, and preliminary results of the non-human primates eye study. BMC Ophthalmol. 2023;23:53.","journal-title":"BMC Ophthalmol"},{"key":"3665_CR25","doi-asserted-by":"crossref","unstructured":"Pan L, Wang N, Liu W, Huang Z, Zhuo Y, Wu J. Infrequent spontaneous fundus lesions in a Macaca fascicularis cohort from southern China: a case-series study. Open J Clin Med Case Rep. 2024;10:638\u201359.","DOI":"10.52768\/2379-1039\/2248"},{"key":"3665_CR26","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1038\/s41433-024-03137-7","volume":"38","author":"PR Pawar","year":"2024","unstructured":"Pawar PR, Booth J, Neely A, McIlwaine G, Lueck CJ. Nerve fibre organisation in the human optic nerve and chiasm: what do we really know? Eye. 2024;38:2457\u201371.","journal-title":"Eye"},{"key":"3665_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cne.903000103","volume":"300","author":"CA Curcio","year":"1990","unstructured":"Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300:5\u201325.","journal-title":"J Comp Neurol"},{"key":"3665_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000027470","volume":"214","author":"N Furuyoshi","year":"2000","unstructured":"Furuyoshi N, Furuyoshi M, May CA, Hayreh SS, Alm A, Lutjen-Drecoll E. Vascular and glial changes in the retrolaminar optic nerve in glaucomatous monkey eyes. Ophthalmologica. 2000;214:24\u201332.","journal-title":"Ophthalmologica"},{"key":"3665_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/(SICI)1096-9861(19970714)383:4<459::AID-CNE5>3.0.CO;2-1","volume":"383","author":"M Herbin","year":"1997","unstructured":"Herbin M, Boire D, Ptito M. Size and distribution of retinal ganglion cells in the St. Kitts green monkey (Cercopithecus aethiops sabeus). J Comp Neurol. 1997;383:459\u201372.","journal-title":"J Comp Neurol"},{"key":"3665_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0197-4580(96)00038-3","volume":"17","author":"CB Kim","year":"1996","unstructured":"Kim CB, Tom BW, Spear PD. Effects of aging on the densities, numbers, and sizes of retinal ganglion cells in rhesus monkey. Neurobiol Aging. 1996;17:431\u20138.","journal-title":"Neurobiol Aging"},{"key":"3665_CR31","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/0042-6989(89)90131-4","volume":"29","author":"LC Silveira","year":"1989","unstructured":"Silveira LC, Picanco-Diniz CW, Sampaio LF, Oswaldo-Cruz E. Retinal ganglion cell distribution in the cebus monkey: a comparison with the cortical magnification factors. Vis Res. 1989;29:1471\u201383.","journal-title":"Vis Res"},{"key":"3665_CR32","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/0042-6989(90)90166-I","volume":"30","author":"H Wassle","year":"1990","unstructured":"Wassle H, Grunert U, Rohrenbeck J, Boycott BB. Retinal ganglion cell density and cortical magnification factor in the primate. Vis Res. 1990;30:1897\u2013911.","journal-title":"Vis Res"},{"key":"3665_CR33","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/bjo.53.11.721","volume":"53","author":"SS Hayreh","year":"1969","unstructured":"Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969;53:721\u201348.","journal-title":"Br J Ophthalmol"},{"key":"3665_CR34","first-page":"OP240","volume":"78","author":"SS Hayreh","year":"1974","unstructured":"Hayreh SS. Anatomy and physiology of the optic nerve head. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:OP240\u201354.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"3665_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000310727","volume":"210","author":"SS Hayreh","year":"1996","unstructured":"Hayreh SS. Blood supply of the optic nerve head. Ophthalmologica. 1996;210:285\u201395.","journal-title":"Ophthalmologica"},{"key":"3665_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijdevneu.2013.06.007","volume":"32","author":"Y Yan","year":"2014","unstructured":"Yan Y, Nair G, Li L, Patel S, Wilson M, Hu X, et al. In vivo evaluation of optic nerve development in non-human primates by using diffusion tensor imaging. Int J Dev Neurosci. 2014;32:64\u20138.","journal-title":"Int J Dev Neurosci"},{"key":"3665_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exer.2011.03.020","volume":"93","author":"C Stowell","year":"2011","unstructured":"Stowell C, Arbogast B, Cioffi G, Burgoyne C, Zhou A. Retinal proteomic changes following unilateral optic nerve transection and early experimental glaucoma in non-human primate eyes. Exp Eye Res. 2011;93:13\u201328.","journal-title":"Exp Eye Res"},{"key":"3665_CR38","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1167\/iovs.11-9130","volume":"53","author":"J Dwelle","year":"2012","unstructured":"Dwelle J, Liu S, Wang B, McElroy A, Ho D, Markey MK, et al. Thickness, phase retardation, birefringence, and reflectance of the retinal nerve fiber layer in normal and glaucomatous non-human primates. Investig Ophthalmol Vis Sci. 2012;53:4380\u201395.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR39","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0161-6420(89)32718-7","volume":"96","author":"FS Mikelberg","year":"1989","unstructured":"Mikelberg FS, Drance SM, Schulzer M, Yidegiligne HM, Weis MM. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology. 1989;96:1325\u20138.","journal-title":"Ophthalmology"},{"key":"3665_CR40","first-page":"1342","volume":"27","author":"RM Sanchez","year":"1986","unstructured":"Sanchez RM, Dunkelberger GR, Quigley HA. The number and diameter distribution of axons in the monkey optic nerve. Investig Ophthalmol Vis Sci. 1986;27:1342\u201350.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR41","doi-asserted-by":"crossref","unstructured":"Takemura H, Palomero-Gallagher N, Axer M, Grassel D, Jorgensen MJ, Woods R, et al. Anatomy of nerve fiber bundles at micrometer-resolution in the vervet monkey visual system. Elife. 2020;9:e55444.","DOI":"10.7554\/eLife.55444"},{"key":"3665_CR42","first-page":"736","volume":"31","author":"JB Jonas","year":"1990","unstructured":"Jonas JB, Muller-Bergh JA, Schlotzer-Schrehardt UM, Naumann GO. Histomorphometry of the human optic nerve. Investig Ophthalmol Vis Sci. 1990;31:736\u201344.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1096-9861(20010122)429:4<541::AID-CNE3>3.0.CO;2-5","volume":"429","author":"JH Sandell","year":"2001","unstructured":"Sandell JH, Peters A. Effects of age on nerve fibers in the rhesus monkey optic nerve. J Comp Neurol. 2001;429:541\u201353.","journal-title":"J Comp Neurol"},{"key":"3665_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/eye.1992.29","volume":"6","author":"A Hendrickson","year":"1992","unstructured":"Hendrickson A. A morphological comparison of foveal development in man and monkey. Eye. 1992;6:136\u201344.","journal-title":"Eye"},{"key":"3665_CR45","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/bjo.77.5.302","volume":"77","author":"WW Dawson","year":"1993","unstructured":"Dawson WW, Brooks DE, Hope GM, Samuelson DA, Sherwood MB, Engel HM, et al. Primary open angle glaucomas in the rhesus monkey. Br J Ophthalmol. 1993;77:302\u201310.","journal-title":"Br J Ophthalmol"},{"key":"3665_CR46","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1167\/iovs.04-1160","volume":"46","author":"B Fortune","year":"2005","unstructured":"Fortune B, Wang L, Bui BV, Burgoyne CF, Cioffi GA. Idiopathic bilateral optic atrophy in the rhesus macaque. Investig Ophthalmol Vis Sci. 2005;46:3943\u201356.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR47","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1096\/fj.04-3525fje","volume":"19","author":"S Umeda","year":"2005","unstructured":"Umeda S, Suzuki MT, Okamoto H, Ono F, Mizota A, Terao K, et al. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 2005;19:1683\u20135.","journal-title":"FASEB J"},{"key":"3665_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.10.6.7","volume":"10","author":"KH Lin","year":"2021","unstructured":"Lin KH, Tran T, Kim S, Park S, Stout JT, Chen R, et al. Advanced retinal imaging and ocular parameters of the rhesus macaque eye. Transl Vis Sci Technol. 2021;10:7.","journal-title":"Transl Vis Sci Technol"},{"key":"3665_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.10.9.20","volume":"10","author":"LR Pasquale","year":"2021","unstructured":"Pasquale LR, Gong L, Wiggs JL, Pan L, Yang Z, Wu M, et al. Development of primary open angle glaucoma-like features in a rhesus macaque colony from Southern China. Transl Vis Sci Technol. 2021;10:20.","journal-title":"Transl Vis Sci Technol"},{"key":"3665_CR50","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901\u201311.","journal-title":"JAMA"},{"key":"3665_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100875","volume":"80","author":"G Beykin","year":"2021","unstructured":"Beykin G, Norcia AM, Srinivasan VJ, Dubra A, Goldberg JL. Discovery and clinical translation of novel glaucoma biomarkers. Prog Retin Eye Res. 2021;80:100875.","journal-title":"Prog Retin Eye Res"},{"key":"3665_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41433-019-0687-5","volume":"34","author":"R Wormald","year":"2020","unstructured":"Wormald R, Virgili G, Azuara-Blanco A. Systematic reviews and randomised controlled trials on open angle glaucoma. Eye. 2020;34:161\u20137.","journal-title":"Eye"},{"key":"3665_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exer.2015.06.005","volume":"141","author":"CF Burgoyne","year":"2015","unstructured":"Burgoyne CF. The non-human primate experimental glaucoma model. Exp Eye Res. 2015;141:57\u201373.","journal-title":"Exp Eye Res"},{"key":"3665_CR54","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1159\/000533865","volume":"66","author":"X Jia","year":"2023","unstructured":"Jia X, Yu Z, Wu J, Hou S, Du Y, Zhu Y, et al. Discovery of clinical manifestations in spontaneous glaucoma suspect nonhuman primates. Ophthalmic Res. 2023;66:1406\u201316.","journal-title":"Ophthalmic Res"},{"key":"3665_CR55","doi-asserted-by":"crossref","unstructured":"Sosnowik S, Swain DL, Liu N, Fan S, Toris CB, Gong H. Endothelial glycocalyx morphology in different flow regions of the aqueous outflow pathway of normal and laser-induced glaucoma monkey eyes. Cells. 2022;11:2452.","DOI":"10.3390\/cells11152452"},{"key":"3665_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101801","volume":"3","author":"D Sun","year":"2022","unstructured":"Sun D, Wang B, Yang Z, Zhan Z, Li J, Lan Y. Protocol for laser-induced chronic ocular hypertension and intracameral injection in nonhuman primates. STAR Protoc. 2022;3:101801.","journal-title":"STAR Protoc"},{"key":"3665_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2012.07.012","volume":"103","author":"SK Gardiner","year":"2012","unstructured":"Gardiner SK, Fortune B, Wang L, Downs JC, Burgoyne CF. Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma. Exp Eye Res. 2012;103:1\u20138.","journal-title":"Exp Eye Res"},{"key":"3665_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48054-y","volume":"9","author":"WS Lambert","year":"2019","unstructured":"Lambert WS, Carlson BJ, Ghose P, Vest VD, Yao V, Calkins DJ. Towards a microbead occlusion model of glaucoma for a non-human primate. Sci Rep. 2019;9:11572.","journal-title":"Sci Rep"},{"key":"3665_CR59","doi-asserted-by":"crossref","unstructured":"Moshiri A, Fang F, Zhuang P, Huang H, Feng X, Li L, et al. Silicone oil-induced glaucomatous neurodegeneration in rhesus macaques. Int J Mol Sci. 2022;23:15896.","DOI":"10.3390\/ijms232415896"},{"key":"3665_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88690-x","volume":"11","author":"F Fang","year":"2021","unstructured":"Fang F, Zhang J, Zhuang P, Liu P, Li L, Huang H, et al. Chronic mild and acute severe glaucomatous neurodegeneration derived from silicone oil-induced ocular hypertension. Sci Rep. 2021;11:9052.","journal-title":"Sci Rep"},{"key":"3665_CR61","doi-asserted-by":"crossref","unstructured":"Zhang J, Fang F, Li L, Huang H, Webber HC, Sun Y, et al. A reversible silicon oil-induced ocular hypertension model in mice. J Vis Exp. 2019;153:60409.","DOI":"10.3791\/60409"},{"key":"3665_CR62","doi-asserted-by":"crossref","unstructured":"Zhang J, Li L, Huang H, Fang F, Webber HC, Zhuang P, et al. Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse. Elife. 2019;8:e45881.","DOI":"10.7554\/eLife.45881"},{"key":"3665_CR63","first-page":"145","volume":"42","author":"JH Fingert","year":"2001","unstructured":"Fingert JH, Clark AF, Craig JE, Alward WL, Snibson GR, McLaughlin M, et al. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Investig Ophthalmol Vis Sci. 2001;42:145\u201352.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR64","first-page":"126","volume":"19","author":"HA Quigley","year":"1980","unstructured":"Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells. Investig Ophthalmol Vis Sci. 1980;19:126\u201336.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR65","first-page":"83","volume":"14","author":"AC Arnold","year":"2001","unstructured":"Arnold AC. Ischemic optic neuropathies. Ophthalmol Clin North Am. 2001;14:83\u201398.","journal-title":"Ophthalmol Clin North Am"},{"key":"3665_CR66","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/sj.eye.6701562","volume":"18","author":"SS Hayreh","year":"2004","unstructured":"Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004;18:1188\u2013206.","journal-title":"Eye"},{"key":"3665_CR67","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/archophthalmol.2011.351","volume":"129","author":"SalgadoC Vilson","year":"2011","unstructured":"Vilson SalgadoC, Miller F, Bernstein NR. SL. Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch Ophthalmol. 2011;129:1583\u201391.","journal-title":"Arch Ophthalmol"},{"key":"3665_CR68","first-page":"592","volume":"103","author":"GA Cioffi","year":"2005","unstructured":"Cioffi GA. Ischemic model of optic nerve injury. Trans Am Ophthalmol Soc. 2005;103:592\u2013613.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3665_CR69","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1177\/112067219900901S12","volume":"9","author":"GA Cioffi","year":"1999","unstructured":"Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol. 1999;9:S34\u20136.","journal-title":"Eur J Ophthalmol"},{"key":"3665_CR70","first-page":"135","volume":"5","author":"S Orgul","year":"1996","unstructured":"Orgul S, Cioffi GA, Bacon DR, Van Buskirk EM. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma. 1996;5:135\u20138.","journal-title":"J Glaucoma"},{"key":"3665_CR71","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/bjo.58.12.955","volume":"58","author":"SS Hayreh","year":"1974","unstructured":"Hayreh SS. Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol. 1974;58:955\u201363.","journal-title":"Br J Ophthalmol"},{"key":"3665_CR72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10384-015-0373-5","volume":"59","author":"SL Bernstein","year":"2015","unstructured":"Bernstein SL, Miller NR. Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses. Jpn J Ophthalmol. 2015;59:135\u201347.","journal-title":"Jpn J Ophthalmol"},{"key":"3665_CR73","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1167\/iovs.07-1651","volume":"49","author":"CS Chen","year":"2008","unstructured":"Chen CS, Johnson MA, Flower RA, Slater BJ, Miller NR, Bernstein SL. A primate model of nonarteritic anterior ischemic optic neuropathy. Investig Ophthalmol Vis Sci. 2008;49:2985\u201392.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR74","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1167\/iovs.04-0547","volume":"46","author":"N Goldenberg-Cohen","year":"2005","unstructured":"Goldenberg-Cohen N, Guo Y, Margolis F, Cohen Y, Miller NR, Bernstein SL. Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia. Investig Ophthalmol Vis Sci. 2005;46:2716\u201325.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR75","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaapos.2019.01.012","volume":"23","author":"F Teixeira","year":"2019","unstructured":"Teixeira F, Fonseca AC, Pinto F. Acquired and progressive myelinated retinal nerve fibers in neurofibromatosis type 1. J AAPOS. 2019;23:178\u20139.","journal-title":"J AAPOS"},{"key":"3665_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02619-3","volume":"18","author":"EJ Vallender","year":"2023","unstructured":"Vallender EJ, Hotchkiss CE, Lewis AD, Rogers J, Stern JA, Peterson SM, et al. Nonhuman primate genetic models for the study of rare diseases. Orphanet J Rare Dis. 2023;18:20.","journal-title":"Orphanet J Rare Dis"},{"key":"3665_CR77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2018.07.013","volume":"119","author":"JL McBride","year":"2018","unstructured":"McBride JL, Neuringer M, Ferguson B, Kohama SG, Tagge IJ, Zweig RC, et al. Discovery of a CLN7 model of Batten disease in non-human primates. Neurobiol Dis. 2018;119:65\u201378.","journal-title":"Neurobiol Dis"},{"key":"3665_CR78","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1006\/geno.1997.4744","volume":"42","author":"P Luzi","year":"1997","unstructured":"Luzi P, Rafi MA, Victoria T, Baskin GB, Wenger DA. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate. Genomics. 1997;42:319\u201324.","journal-title":"Genomics"},{"key":"3665_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105465","volume":"158","author":"LS Sherman","year":"2021","unstructured":"Sherman LS, Su W, Johnson AL, Peterson SM, Cullin C, Lavinder T, et al. A novel non-human primate model of Pelizaeus-Merzbacher disease. Neurobiol Dis. 2021;158:105465.","journal-title":"Neurobiol Dis"},{"key":"3665_CR80","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI123980","volume":"129","author":"A Moshiri","year":"2019","unstructured":"Moshiri A, Chen R, Kim S, Harris RA, Li Y, Raveendran M, et al. A nonhuman primate model of inherited retinal disease. J Clin Investig. 2019;129:863\u201374.","journal-title":"J Clin Investig"},{"key":"3665_CR81","doi-asserted-by":"publisher","first-page":"107825","DOI":"10.1016\/j.exer.2019.107825","volume":"189","author":"SM Peterson","year":"2019","unstructured":"Peterson SM, McGill TJ, Puthussery T, Stoddard J, Renner L, Lewis AD, et al. Bardet-Biedl Syndrome in rhesus macaques: a nonhuman primate model of retinitis pigmentosa. Exp Eye Res. 2019;189:107825.","journal-title":"Exp Eye Res"},{"key":"3665_CR82","first-page":"474","volume":"64","author":"B Ksander","year":"2023","unstructured":"Ksander B, Shah M, Krasniqi D, Gregory-Ksander MS, Rosenzweig-Lipson S, Broniowska K, et al. Epigenetic reprogramming- A novel gene therapy that restores vision loss in a nonhuman primate model of NAION. Investig Ophthalmol Vis Sci. 2023;64:474.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR83","first-page":"5223","volume":"64","author":"M Shah","year":"2023","unstructured":"Shah M, Krasniqi D, Gregory-Ksander MS, Rosenzweig-Lipson S, Broniowska K, Wathier M, et al. Non-human primate laser-induced NAION model for assessing neuro-rejuvenating gene therapies. Investig Ophthalmol Vis Sci. 2023;64:5223.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3665_CR84","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"29","author":"JR Mendell","year":"2021","unstructured":"Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, et al. Current clinical applications of in vivo gene therapy with AAVs. Mol Ther. 2021;29:464\u201388.","journal-title":"Mol Ther"},{"key":"3665_CR85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtm.2019.08.011","volume":"15","author":"L Weed","year":"2019","unstructured":"Weed L, Ammar MJ, Zhou S, Wei Z, Serrano LW, Sun J, et al. Safety of same-eye subretinal sequential readministration of AAV2-hRPE65v2 in non-human primates. Mol Ther Methods Clin Dev. 2019;15:133\u201348.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3665_CR86","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.omtm.2021.09.013","volume":"23","author":"DJ Calkins","year":"2021","unstructured":"Calkins DJ, Yu-Wai-Man P, Newman NJ, Taiel M, Singh P, Chalmey C, et al. Biodistribution of intravitreal (lenadogene) nolparvovec gene therapy in nonhuman primates. Mol Ther Methods Clin Dev. 2021;23:307\u201318.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3665_CR87","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awac421","volume":"146","author":"NJ Newman","year":"2023","unstructured":"Newman NJ, Yu-Wai-Man P, Subramanian PS, Moster ML, Wang AG, Donahue SP, et al. Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy. Brain. 2023;146:1328\u201341.","journal-title":"Brain"},{"key":"3665_CR88","unstructured":"Yu-Wai-Man P, Newman NJ, Biousse V, Carelli V, Moster ML, Vignal-Clermont C, et al. Five-year outcomes of lenadogene nolparvovec gene therapy in Leber hereditary optic neuropathy. JAMA Ophthalmol. 2024;142:5375."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03665-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T11:05:41Z","timestamp":1746011141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03665-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3665"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03665-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}